On December 20-22, 2019, at the invitation of the Committee of Indian Drug Control Officials, Mr.  James Ho, CEO of Beijing Memorial Pharmaceutical Research Co., Ltd. went to Chennai, the fourth largest city in India, to participate in the 71st Indian Pharmaceutical Congress.

And on the morning of December 21, he gave a keynote speech on the topic of "China-India Pharmaceutical Industry Cooperation under China's Policy Innovation", sharing China's favorable policies with Indian practitioners, hoping to promote a brighter China-India pharmaceutical cooperation future.

In his speech, James Ho deeply analyzed the general environment of China's pharmaceutical market from social, economic, and policy aspects, combined with more than ten years of experience in the international pharmaceutical industry, and put forward his own views on the direction of cooperation in the pharmaceutical industry between China and India.

“China and India are both big pharmaceutical countries, but they have different advantages.” James Ho pointed out that China has obvious advantages in the production of APIs. In the past, India mainly imported APIs from China to produce generic drugs. Because of the abundant available capital, with government policy support, China also has great advantages in innovative drugs.

“India has been very successful in the process and technology of generic drugs. We have very good experience to follow. This will help improve the quality of generic drugs in China. Secondly, the cost of clinical research in India is very low, and they have enough test sites .The subjects can greatly save R&D expenses, and the cost is only about 1/3 of China's.”

"If China and India, the two major pharmaceutical countries, cooperate and complement each other's strengths, they can produce more cheaper, effective and safe drugs for the people of the two countries."

After the speech, the organizer of the conference presented James Ho with a certificate of honor as a lecturer at the 71st Indian Pharmaceutical Congress, and put on him a precious cashmere shawl as a gift, which is regarded as the highest etiquette for receiving guests in India.

Later that day, James Ho attended the 2019 Appreciation Dinner of the Indian Pharmaceutical Association, had a cordial exchange with representatives of the pharmaceutical industry who came to the meeting, and forged a deep international friendship.

At the appreciation dinner, the Indian Pharmaceutical Association also awarded the "International Honor Award" certificate to Mr. James Ho, in recognition of his contributions to the China-Indian pharmaceutical cooperation in the past year.

It is reported that Memorial Pharmaceutical is vigorously developing the "CliniExpert" service platform for international clinical trials, providing clinical reference drug export, packaging and storage, recycling and destruction, logistics and distribution services.

James Ho expressed the hope that this trip to India will be a worthwhile trip, so that more people can learn about an open China, and he hopes that the day when China and other countries in the world develop large-scale medical cooperation will come soon!